Oral anticoagulant switching in patients with atrial fibrillation: a scoping review
Introduction Oral anticoagulants (OACs) prevent stroke in patients with atrial fibrillation (AF).
Several factors may cause OAC switching. Objectives To examine the phenomenon of OAC …
Several factors may cause OAC switching. Objectives To examine the phenomenon of OAC …
Ischemic stroke severity and mortality in patients with and without atrial fibrillation
Background Our objective was to investigate stroke severity and subsequent rate of mortality
among patients with and without atrial fibrillation (AF). Contemporary data on stroke severity …
among patients with and without atrial fibrillation (AF). Contemporary data on stroke severity …
Changing paradigms: from prevention of thromboembolic events to improved survival in patients with atrial fibrillation
C Escobar, AJ Camm - EP Europace, 2021 - academic.oup.com
Atrial fibrillation is associated with a five-fold increase in the risk of stroke. Current guidelines
recommend the use of the CHA2DS2-VASc score to stratify the risk of stroke. In addition …
recommend the use of the CHA2DS2-VASc score to stratify the risk of stroke. In addition …
The value of anticoagulation management combining telemedicine and self-testing in cardiovascular diseases: a meta-analysis of randomized controlled trials
Y Huang, Y Xie, L Huang, Z Han - Therapeutics and Clinical Risk …, 2023 - Taylor & Francis
Purpose No consensus has been established on the safety and effectiveness of out-of-
hospital management of Vitamin K antagonists (VKA) therapy combining portable …
hospital management of Vitamin K antagonists (VKA) therapy combining portable …
Real-world evaluation of perception, convenience and anticoagulant treatment satisfaction of patients with atrial fibrillation switched from long-term vitamin K …
EK Choi, YS Lee, AKC Chern, P Jiampo… - Open …, 2020 - openheart.bmj.com
Background and purpose Real-world data about treatment convenience and satisfaction in
Asian non-valvular atrial fibrillation (NVAF) patients after switching from vitamin K …
Asian non-valvular atrial fibrillation (NVAF) patients after switching from vitamin K …
Recomendaciones de expertos en la mejora de la prevención efectiva del ictus isquémico en la fibrilación auricular no valvular: papel del rivaroxabán
AIP Cabeza, JN Portero, MR Ortiz, LT Sánchez… - Revista Española de …, 2020 - Elsevier
La fibrilación auricular aumenta de manera marcada el riesgo de ictus isquémico. A pesar
de que los antagonistas de la vitamina K (AVK) reducen ese riesgo, tienen una eficacia …
de que los antagonistas de la vitamina K (AVK) reducen ese riesgo, tienen una eficacia …
Pharmacogenetics of warfarin dosing in Chinese adults with nonvalvular atrial fibrillation
Y Zhu, J You, X Gu, H Zhu, J Liu - European journal of clinical …, 2023 - Springer
Background The guide for the use of genotype-guided warfarin dosing in patients for the
treatment of non-valvular atrial fibrillation (AF) is still lacking. Aim We aimed to evaluate …
treatment of non-valvular atrial fibrillation (AF) is still lacking. Aim We aimed to evaluate …
A new index to predict quality of anticoagulation control in patients on vitamin K antagonists: the DAFNE score
Aim: To derive a new clinical score to improve the prediction of those at risk of poor
International Normalized Ratio control among patients with atrial fibrillation taking vitamin K …
International Normalized Ratio control among patients with atrial fibrillation taking vitamin K …
A retrospective cohort study of pharmacogenetics of warfarin dosing in Chinese Adults with nonvalvular atrial fibrillation
Y Zhu, J You, X Gu, H Zhu, J Liu - 2022 - researchsquare.com
Background: The guide for the use of genotype-guided warfarin dosing in patients for the
treatment of non-valvular atrial fbrillation (NVAF) is still lacking. Aim: We aimed to evaluate …
treatment of non-valvular atrial fbrillation (NVAF) is still lacking. Aim: We aimed to evaluate …